XC 386: A new antiplatelet agent

Thrombosis Research - Tập 36 - Trang 113-122 - 1984
Jih-Pyang Wang1, Mei-Feng Hsu2, Huei-Yann Tsai, Li-Jiau Huang3, Che-Ming Teng4
1Department of Pharmacology, China Medical College, Taichung, Taiwan, R.O.C.
2Department of Biochemistry, China Medical College, Taichung, Taiwan, R.O.C.
3School of Pharmacy, China Medical College, Taichung, Taiwan, R.O.C.
4Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, R.O.C.

Tài liệu tham khảo

Kuo, 1984, Synthesis and analgesic and antiinflammatory activities of 3,4-dimethylpyrano[2,3-c]pyrazole-6-one derivatives, J. Med. Chem., 27, 1004, 10.1021/jm00370a020 Kinlough-Rathbone, 1977, Properties of washed human platelets, Thrombos. Haemostas., 37, 291, 10.1055/s-0038-1649230 O'Brien, 1962, Platelet aggregation .II. Some results from a new method of study, J. Clin. Pathol., 15, 452, 10.1136/jcp.15.5.452 Yamazaki, 1975, Hyperaggregability of platelets in thromboembolic disorders, Thrombos. Diathes. Haemostas., 34, 94, 10.1055/s-0038-1651449 Villa, 1979, The inhibitory effect of aspirin on platelet and vascular prostaglandins in rat cannot be completely dissociated, Br. J. Haematol., 42, 425, 10.1111/j.1365-2141.1979.tb01151.x Verhaeghe, 1976, Effect of nitroprusside on smooth muscle and adrenergic nerve terminals in isolated blood vessels, J. Pharmac. exp. Ther., 199, 269 Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature (New Biol.), 231, 232, 10.1038/newbio231232a0 Vargaftig, 1981, Present concepts on the mechanisms of platelet aggregation, Biochem. Pharmacol., 24, 263, 10.1016/0006-2952(81)90052-6 Izrael, 1974, Effect of a fast removal of plasmatic ADP by the creatine phosphate and creatine phosphokinase system on human platelet function in vitro, 187 Hamberg, 1975, Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides, 72, 2994 Svensson, 1976, On the formation and effects of thromboxane A2in human platelets, Acta Physiol. Scad., 98, 285, 10.1111/j.1748-1716.1976.tb10313.x Smith, 1976, Platelet prostaglandin production and its implications, Vol. 2, 247 Bills, 1976, Metabolism of [14c]arachidonic acid by human platelets, Biochim. biophys. Acta, 424, 303, 10.1016/0005-2760(76)90198-3 Rittenhouse-Simmons, 1977, Mobilization of arachidonic acid in human platelet kinetics and Ca2+dependency, Biochim. biophys. Acta, 488, 370, 10.1016/0005-2760(77)90196-5 Rittenhouse-Simmons, 1978, The activation by Ca2+ of platelet phosphokinase A2, 543, 409 Wong, 1979, Calmodulin stimulates human platelet phospholipase A2, Biochem. biophys. Res. Commun., 90, 473, 10.1016/0006-291X(79)91259-2 Smoake, 1974, Cyclic 3′,5′-nucleotide phosphodiesterase, 341, 402 Cheung, 1970, Cyclic 3′,5′-nucleotide phosphodiesterase, 38, 533 Rapetina, 1979, Stimulation of phosphatidic acid production in platelets precedes the formation of arachidonate and parallels the release of serotonin, Biochim. biophys. Acta, 537, 394, 10.1016/0005-2760(79)90072-9 Lapetina, 1982, Regulation of arachidonic acid production: role of phosqioliqase C and A2, Trend in Pharmacol., 115, 10.1016/0165-6147(82)91046-X White, 1980, The effects of trifluoperazine, an inhibitor of calmodulin on platelet function, Thromb. Res., 18, 279, 10.1016/0049-3848(80)90194-2 Cheung, 1980, Calmodulin plays a pivotal role in cellular regulation, Science, 207, 19, 10.1126/science.6243188